Relapse Timing Is Associated With Distinct Evolutionary Dynamics in Diffuse Large B-Cell Lymphoma
Laura K. Hilton(BC Cancer Agency), David W. Scott, Alina S. Gerrie(University of British Columbia), Pedro Farinha, Manuela Cruz(Simon Fraser University), Jeffrey W. Craig(University of British Columbia), Kerry J. Savage(BC Cancer Agency), Laurie H. Sehn(BC Cancer Agency), Susana Ben‐Neriah(Apple (Israel)), Brett Collinge, Robert Kridel(BC Cancer Agency), Diego Villa(University of British Columbia), Christian Steidl(Spinal Cord Injury BC), Graham W. Slack(BC Cancer Agency), Michael Crump(Princess Margaret Cancer Centre), Ciara L. Freeman(Moffitt Cancer Center), Annette E. Hay(Queen's University), Andrew Roth(Canadian Centre for Applied Research in Cancer Control), Henry S. Ngu(Spinal Cord Injury BC), Marco A. Marra(BC Cancer Agency), Ryan D. Morin(Simon Fraser University), Jasper Wong, Aly Karsan(University of British Columbia), John Kuruvilla(Princess Margaret Cancer Centre), Merrill Boyle, Kostiantyn Dreval(National Center for Toxicological Research), Barbara Meissner, Kevin Song(Vancouver General Hospital), Christopher Rushton(Simon Fraser University), Judith Anula Rodrigo(University of British Columbia), Lois E. Shepherd(Ontario Institute for Cancer Research)
Cited by 50
Related Papers
<i>K-ras</i> Mutations and Benefit from Cetuximab in Advanced Colorectal Cancer
|New England Journal of Medicine|2008|3.6k
Tumor Microsatellite-Instability Status as a Predictor of Benefit from Fluorouracil-Based Adjuvant Chemotherapy for Colon Cancer
|New England Journal of Medicine|2003|2.1k
The NIH Roadmap Epigenomics Mapping Consortium
|Nature Biotechnology|2010|2k
The clonal and mutational evolution spectrum of primary triple-negative breast cancers
|Nature|2012|2k
Tumor-Associated Macrophages and Survival in Classic Hodgkin's Lymphoma
|New England Journal of Medicine|2010|1.3k